New ways to find antibiotics for drug-resistant infections.
Innovative technologies to transform antibiotic discovery. Administrative Core
This study is working to find new antibiotics to help treat tough infections caused by bacteria like Klebsiella pneumoniae and Pseudomonas aeruginosa, so patients can have better options for their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10670185 on NIH RePORTER |
What this research studies
This research aims to create a center focused on discovering new antibiotics to combat serious drug-resistant infections caused by bacteria like Klebsiella pneumoniae and Pseudomonas aeruginosa. The project will involve collaboration among scientists, industry partners, and healthcare professionals to develop new antimicrobial candidates and innovative drug discovery methods. Patients may benefit from new treatments that effectively target these challenging infections, which currently have limited options.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from infections caused by drug-resistant bacteria, particularly those involving Klebsiella pneumoniae or Pseudomonas aeruginosa.
Not a fit: Patients with infections caused by non-drug-resistant bacteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that effectively treat drug-resistant infections.
How similar studies have performed: Other research initiatives have shown promise in developing new antibiotics through innovative approaches, indicating that this research builds on successful strategies.
Where this research is happening
Cambridge, United States
- Broad Institute, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Hung, Deborah T — Broad Institute, INC.
- Study coordinator: Hung, Deborah T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.